Anjali Sharma

Anjali Sharma

Auto-generated profile, based on publicly available information

Anjali Sharma

CDSCO, FDA Bhawan, New Delhi, India

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2022 in BioMed Research International
Verified
Journal Article
Open access
PDF file
ASAshwani Sharma
Ashwani Sharma
TVTarun Virmani
Tarun Virmani
VPVipluv Pathak
Vipluv Pathak
ASAnjali Sharma
Anjali Sharma
KPKamla Pathak
Kamla Pathak
DPDevender Pathak
Devender Pathak
The global COVID‐19 (coronavirus disease 2019) pandemic, which was caused by the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), has resulted in a significant loss of human life around the world. The SARS‐CoV‐2 has caused significant problems to medical systems and healthcare facilities due to its unexpected global expansion. Despite all of the efforts, developing effective treatments, diagnostic techniques, and vaccinations for this unique virus is a top priority and takes a long time. However, the foremost step in vaccine development is to identify possible antigens for a vaccine. The traditional method was time taking, but after the breakthrough technology of reverse vaccinology (RV) was introduced in 2000, it drastically lowers the time needed to detect antigens ranging from 5–15 years to 1–2 years. The different RV tools work based on machine learning (ML) and artificial intelligence (AI). Models based on AI and ML have shown promising solutions in accelerating the discovery and optimization of new antivirals or effective vaccine candidates. In the present scenario, AI has been extensively used for drug and vaccine research against SARS‐COV‐2 therapy discovery. This is more useful for the identification of potential existing drugs with inhibitory human coronavirus by using different datasets. The AI tools and computational approaches have led to speedy research and the development of a vaccine to fight against the coronavirus. Therefore, this paper suggests the role of artificial intelligence in the field of clinical trials of vaccines and clinical practices using different tools.

1 January 2025 in Journal of Nutrition and Metabolism
Verified
Journal Article
Open access
ASAshwani Sharma
Ashwani Sharma
DGDalapathi Gugulothu
Dalapathi Gugulothu
TVTarun Virmani
Tarun Virmani
ASAnjali Sharma
Anjali Sharma
GKGirish Kumar
Girish Kumar
MIMd. Torequl Islam
Md. Torequl Islam
Aegle marmelos (L.) Corrêa, commonly known as the bael fruit tree, is a member of the Rutaceae family and holds significance in Ayurvedic herbal medicine due to its myriad therapeutic properties. This paper seeks to delve into the diverse benefits offered by the bael fruit tree, exploring various plant parts, including leaves, fruit, bark, and seeds, all of which contain bioactive compounds with therapeutic potential. The bael fruit, with its diverse phytochemical profile, exhibits potential health benefits ranging from radioprotection and antibacterial properties to antioxidant and hepatoprotective effects. Additionally, this review highlights the limited preclinical studies on AMs’ efficacy in treating neurological disorders, emphasizing the need for more clinical trials to validate its potency and safety. Specifically, the effects and mechanisms of AM extract in addressing Alzheimer’s disease, anxiety, depression, epilepsy and Parkinson’s disease are explored. In conclusion, AM emerges as a plant of considerable nutritional and pharmacological value, with the potential to contribute significantly to the treatment of neurological disorders. Despite its promising attributes, the limited preclinical studies necessitate further clinical trials to confirm its efficacy. This review consolidates relevant studies, offering insights into AMs’ ethnobotany, chemical constituents, pharmacological properties and potential application in neurological disorders. The comprehensive examination underscores the need for continued research to unlock the full therapeutic potential of this versatile plant.

12 October 2023 in Acta Neurologica Scandinavica
Verified
Journal Article
Open access
PDF file
AMAmarjeet
Amarjeet
RBRaja Babu
Raja Babu
AMAbhipsa Mohapatra
Abhipsa Mohapatra
BPBhaskaranand Pancholi
Bhaskaranand Pancholi
DGDebapriya Garabadu
Debapriya Garabadu
AAA. K. Azad
A. K. Azad
Myelin is a spiral compilation of uniformly thick membranes around the axon in an alternating fashion, and it is formed by a complicated process known as myelination. Myelin sheaths are responsible for various physiological functions such as metabolism, rapid nerve conduction, and maintaining ionic and water homeostasis in the brain. Lipid is one of the major components in the myelin, which includes cholesterol, ceramide, and their derivatives, such as galactosylceramide, sulfatide, and gangliosides. Ceramide and its derivatives are synthesised by various ceramide biosynthetic pathways such as de novo, salvage, sphingomyelinase, and recycling of exogenous ceramide. At an appropriate level, ceramide facilitates the development of the nervous system, cell proliferation, autophagy, and apoptosis, which are responsible for normal functioning, but when the level is altered from normal, it results in mitochondrial dysfunction or cell death through autophagy and apoptosis. The ceramide level increases, especially in the mitochondria. Ceramide level increases in response to oxidative stress which is mediated by inflammatory cytokines. Due to mitochondrial dysfunction, an energy-deficient condition is created because of disruption in the electron transport chain, which results in the death of neurons and glial cells, which subsequently cause demyelination and degeneration of axon. Losing myelin while axons remain relatively intact is the characteristic feature of demyelinating diseases. The primary element of demyelinating disorder is damage, malfunction, failure, or death of mitochondria. These disturbances may occur due to direct or indirect interaction of ceramide with mitochondria. There are several risk factors for demyelination, such as viruses, bacteria, fungi, trauma, obesity, vitamin D deficiency, and genetic and environmental factors. Thus, the review is mainly aimed towards the interaction between ceramide and mitochondria during demyelination.